Amgen

Selected news for the company - Amgen, collected since 10/2017. Recent stories appear in instanttechnews.com and pioneeringminds.com. This company shares news with Medical Research, Novartis, Merck, Celgene, Biotech and hundreds of others.

Please provide a valid email address.

Selected Headines

Date Headline (link) Source Relevant Snippet
2/23/2021 Autoinjectors Market 2020 Trends, Market Share, Industry Size, Opportunities, Analysis and Forecast by 2026 instanttechnews.com ... ideas to give them a competitive advantage in the global Autoinjectors market. Show how other players compete in the global Autoinjectors Autoinjectors market.Top 10 Companies in the Autoinjectors Market Research Report:Ypsomed, Abbvie, Amgen , Teva, AstraZeneca, Biogen, Eli Lilly, Merck, Mylan, SHL GroupAutoinjectors AutoinjectorsAutoinjectors Market Segmentation:The analysts who wrote the report ranked the global Autoinjectors Autoinjectors ...
2/23/2021 One-Time Gene Editing Treatment Lowers Cholesterol In Monkeys pioneeringminds.com ... The treatment reduced PCSK9 protein levels by 85% and LDL cholesterol levels by 56%. Precision is developing the technique, called ARCUS nuclease gene editing , as an alternative to drug treatments for familial hypercholesterolemia, including Amgen ’s Repatha as well as Sanofi and Regeneron’s Praluent. These results not only contribute to the growing evidence of gene editing for potential therapeutic use but specifically showed that ARCUS nuclease gene editing could ...
2/22/2021 Bradycardia Drugs Market: Qualitative analysis of the leading players and competitive industry scenario | Alkaloids of Australia, Abcam, Albany Molecular Research, Alchem International, Alkaloids Corporation cheshire.media ... report to measure their impact on the production of Bradycardia Drugs market products.Leading key players in the Bradycardia Drugs market are – Alkaloids of Australia, Abcam, Albany Molecular Research, Alchem International, Alkaloids Corporation, Amgen , Centroflora-cms, CR Double-Crane, Fine Chemicals Corporation, GlaxoSmithKline, Guangzhou Hanfang, Hangzhou Vega, HENAN PURUI, Henry Schein, Katsura Chemical, Luyin, Medarex, Merck, Minsheng Group, Pfizer, Phytex Australia, RESONANCE LABORATORIES, ROLABO OUTSOURCING, Sanofi, Laboratoires Servier, TorquePharma ...
2/22/2021 Daiichi Sankyo poaches Kite's research lead Takeshita from parent Gilead FierceBiotech ... with AstraZeneca, is looking to establish itself as a major oncology player, and Takeshita’s experience will no doubt come into play, given his time at Kite as well as at Sorrento, Celgene and Amgen , where he also held high-level R&D positions. This leaves no room for Junichi Koga, Ph.D., who will retire from the company after 12 years. He in fact became the new global head of ...
2/22/2021 Regulatory actions for Feb. 22, 2021 | 22 BioWorld Company Product Description Indication Status Adamis Pharmaceuticals Corp., of San Diego Tempol Superoxide dismutase modulator COVID-19 FDA cleared IND to proceed with phase II/III study enrolling patients early in the infection Amgen Inc., of Thousand Oaks, Calif. Otezla (apremilast) Small-molecule PDE4 inhibitor Mild to moderate plaque psoriasis Submitted supplemental NDA seeking use in patients who are candidates for phototherapy or systemic therapy Astrazeneca plc, of Cambridge, U.K ...
2/22/2021 Immunotherapy Drugs Market Enhancement, Latest Trends, Growth and Opportunity during 2021 to 2026 By Top Key Players such as AbbVie Inc., Amgen Inc., AstraZeneca, GlaxoSmithKline PLC xherald.com Immunotherapy Drugs Market Enhancement, Latest Trends, Growth and Opportunity during 2021 to 2026 By Top Key Players such as AbbVie Inc., Amgen Inc., AstraZeneca, GlaxoSmithKline PLCGlobal Immunotherapy Drugs Market Size, Status And Outlook 2021-2027MarketInsightsReports , one of the world’s prominent market research firms has released a new report on Immunotherapy Drugs Market. The report contains crucial insights on the market which will support the clients to make the ...
2/22/2021 Amgen Submits Supplemental New Drug Application for Otezla® (apremilast) for Adults with Mild-To-Moderate Plaque Psoriasis amgen.com ... locations. Results from the ADVANCE trial demonstrated the potential of Otezla to provide an oral, non-biologic option for these patients," said David M. Reese , M.D., executive vice president of Research and Development at Amgen . "We look forward to working with the FDA to potentially expand access to Otezla and deliver on our commitment to improve outcomes for people living with mild-to-moderate plaque psoriasis."Otezla also demonstrated statistically ...
2/22/2021 Immunotherapy Drugs Market Enhancement, Latest Trends, Growth and Opportunity during 2021 to 2026 By Top Key Players such as AbbVie Inc., Amgen Inc., AstraZeneca, GlaxoSmithKline PLC | FinancialContent Business Page financialcontent.com ... gain competitive advantage. In August 2019, U.S.FDA approved pexidartinib (TURALIO, Daiichi Sankyo) capsules for adult patients with symptomatic tenosynovial giant cell tumor (TGCT). Some of the major players of the market are AbbVie Inc., Amgen Inc., AstraZeneca, GlaxoSmithKline PLC, and F. Hoffmann-La Roche AG, among others.Avail Discount at:Influence of the Immunotherapy Drugs market report:-Comprehensive assessment of all opportunities and risk in the Immunotherapy Drugs market. -Immunotherapy ...
2/22/2021 Global Glottic Cancer Treatment Market 2020 Industry Future Growth – Novartis, Pfizer, Amgen, Eli Lilly, Merck, Cipla, Roche, Bristol-Myers Squibb latestherald.com Global Glottic Cancer Treatment Novartis, Pfizer, Amgen, Eli Lilly, Merck, Cipla, Roche, Bristol-Myers SquibbA recent comprehensive study titled Global Glottic Cancer Treatment Market 2019 by Company, starts with offering a detailed survey of the market, covering the past from 2015-2019 and calculating 2020-2025. The report is just the resource that players need to strengthen their overall growth and exhibit a strong position in the global Glottic Cancer Treatment ...
2/22/2021 Global BiTE Antibodies Market (2021 to 2025) - Price, Sales & Clinical Trials Insights - ResearchAndMarkets.com Business Wire DUBLIN- The "Global BiTE Antibodies Market , Price, Sales & Clinical Trials Insight 2025" report has been added to ResearchAndMarkets.com's offering.This report reviews about the wide spread applications of the market and how it has been able to over-come the challenges that were widely distributed in the cancer therapeutics market for long period of time. The research report summarizes about the scientific advancement that has led to the amalgamation of ...
2/22/2021 360 Financial Inc. Boosts Stake in Amgen Inc. (NASDAQ:AMGN) Dakota Financial News 360 Financial Inc. Boosts Stake in Amgen Inc. (NASDAQ:AMGN) Posted by Doug Madison on Feb 22nd, 2021 // Comments off360 Financial Inc. grew its stake in Amgen Inc. (NASDAQ:AMGN) by 18.0% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 1,969 shares of the medical research company’s stock after buying an additional 300 shares during the period. 360 Financial Inc.’s holdings in Amgen were worth ...
2/22/2021 SeaBridge Investment Advisors LLC Has $4.21 Million Position in Amgen Inc. (NASDAQ:AMGN) Dakota Financial News SeaBridge Investment Advisors LLC Has $4.21 Million Position in Amgen Inc. (NASDAQ:AMGN) Posted by Doug Madison on Feb 22nd, 2021 // Comments offSeaBridge Investment Advisors LLC increased its stake in Amgen Inc. (NASDAQ:AMGN) by 0.3% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 18,305 shares of the medical research company’s stock after purchasing an additional 47 ...
2/21/2021 Global Solid Tumor Drug Market-Sales and revenue estimates and projections by type 2020-2026 | AstraZeneca, Biogen, Baxter, Celgen dailyresearchcorrespondent.com ... factors resulting in hindering or boosting the Solid Tumor Drug market at the global as well as regional level. Numerous dominantMarket players such as AstraZeneca, Biogen, Baxter, Celgene Corporation, Abbott Laboratories, Pfizer Inc, Amgen Limited & Amgen Ireland Limited, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Johnson & Johnson are holding the majority of share of the global Solid Tumor Drug market.Click ...
2/21/2021 Cytokinetics (NASDAQ:CYTK) Upgraded at Zacks Investment Research slatersentinel.com ... muscle activator, for the potential treatment of ALS. Tirasemtiv has been granted orphan drug designation and fast track status by the FDA and orphan medicinal product designation by the EMA. Cytokinetics is collaborating with Amgen Inc. to develop omecamtiv mecarbil, a novel cardiac muscle activator, for the potential treatment of heart failure, and with Astellas Pharma Inc. to develop CK-2127107, a fast skeletal muscle activator, for the potential treatment ...
2/21/2021 Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Beaumont Financial Partners LLC American Banking News Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Beaumont Financial Partners LLCBeaumont Financial Partners LLC increased its stake in shares of Amgen Inc. (NASDAQ:AMGN) by 13.3% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 4,638 shares of the medical research company’s stock after acquiring an additional 544 shares during the period. Beaumont Financial Partners LLC’s holdings in Amgen ...
2/21/2021 Cullen Frost Bankers Inc. Raises Stock Holdings in Amgen Inc. (NASDAQ:AMGN) zolmax.com Cullen Frost Bankers Inc. Raises Stock Holdings in Amgen Inc. (NASDAQ:AMGN) Posted by Bonnie PowleyCullen Frost Bankers Inc. lifted its holdings in shares of Amgen Inc. (NASDAQ:AMGN) by 19.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 54,214 shares of the medical research company’s stock after acquiring an additional 8,834 shares during the quarter. Cullen ...
2/20/2021 Acute Myeloid Leukemia Market worth $17.1 billion by 2024 marketpresswire.com ... as a key restraint to market growth.The major players in the acute myeloid leukemia market are Sanofi (France), AbbVie (US), Bristol-Myers Squibb (US), Novartis (Switzerland), F. Hoffmann-La Roche (Switzerland), Pfizer (US), Amgen (US), Takeda Pharmaceutical (Japan), Gilead Sciences (US), and Celgene (US). Product launches and acquisitions are the key growth strategies adopted by most players in this market.Based on treatment type, the acute myeloid leukemia market ...
2/20/2021 Challenges in Rare Diseases Treatment Market | The rare dise… flickr.com ... in the rare disease segment. However, today several pharma companies at the global level such as Celgene, Takeda, Eli Lilly and Company, Novartis, Bristol Myers Squibb, Alexion Pharmaceuticals, Sanofi, Vertex Pharmaceuticals, Roche, Bluebird Bio, Amgen , Biogen, and many others are working towards the development of novel approaches and novel orphan drugs for rare diseases to bring relief to the affected patients. For more details, visit: www.delveinsight.com/blog/challenges-in-the ...
2/20/2021 Lactose Intolerance Treatment Market is Slated to Witness Tremendous Growth || Leading Players – Ritter Pharmaceuticals, profarma, Amgen Inc, Recordati S.p.A, Novo Nordisk A/S, Johnson & Johnson Services Inc themarketcorrespondent.com ... key factors for market growth.Few of the major competitors currently working in the global lactose intolerance treatment market market are Macleods Pharmaceuticals Ltd, Walter Bushnell, Nature’s Way Products, LLC, Ritter Pharmaceuticals, profarma, Amgen Inc, Recordati S.p.A, Novo Nordisk A/S, Johnson & Johnson Services, Inc, National Enzyme Company, ScimeraMD, Ganeden, Gelda Scientific & Industrial Development, Deerland Enzymes, Inc. and others.Read Complete Details with TOC Here https://www.databridgemarketresearch.com/toc/?dbmr ...
2/20/2021 World Epidermal Expansion Issue Receptor Inhibitor Marketplace (2020-2024) Analysis Covers Best Gamers as Amgen Inc., AstraZeneca Plc, F. Hoffmann-L. a. jewishlifenews.com ... Epidermal Expansion Issue Receptor (EGFR) Inhibitor marketplace is characterised by way of the presence of numerous native and regional gamers and intense festival amongst them. One of the most (industry) contributors out there are: Amgen Inc., AstraZeneca Plc, F. Hoffmann-L. a. Roche Ltd., Novartis AG, Eli Lilly and Co., …All primary areas and international locations were lined within the document. The regional research will assist marketplace gamers to ...